679 related articles for article (PubMed ID: 19508941)
1. Treatment and outcomes of large vessel arteritis.
Borg FA; Dasgupta B
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):325-37. PubMed ID: 19508941
[TBL] [Abstract][Full Text] [Related]
2. [Large vessel vasculitis: giant cell arteritis and Takayasu arteritis].
Petitpierre S; Bart PA; Leimgruber A; Spertini F; Prior J; Spertini F
Rev Med Suisse; 2007 Apr; 3(108):1056-60, 1062-3. PubMed ID: 17552258
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of large vessel vasculitis].
Alvarez-Hernández E
Reumatol Clin; 2011 Dec; 7 Suppl 3():S28-32. PubMed ID: 22152287
[TBL] [Abstract][Full Text] [Related]
4. Neuro-ophthalmic complications in giant cell arteritis.
Borg FA; Salter VL; Dasgupta B
Curr Allergy Asthma Rep; 2008 Jul; 8(4):323-30. PubMed ID: 18606086
[TBL] [Abstract][Full Text] [Related]
5. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
6. Giant cell (temporal) arteritis: an overview and update.
Rahman W; Rahman FZ
Surv Ophthalmol; 2005; 50(5):415-28. PubMed ID: 16139037
[TBL] [Abstract][Full Text] [Related]
7. [Large-vessel vasculitides].
Eklund KK; Pettersson T
Duodecim; 2011; 127(15):1539-47. PubMed ID: 21995124
[TBL] [Abstract][Full Text] [Related]
8. Novel therapeutic strategies for large vessel vasculitis.
Koening CL; Langford CA
Rheum Dis Clin North Am; 2006 Feb; 32(1):173-86, xi. PubMed ID: 16504829
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic update in large vessel vasculitides.
Pérez-Esteban S; González-Gay MA; Castañeda S
Rev Clin Esp (Barc); 2013 Oct; 213(7):338-46. PubMed ID: 23683962
[TBL] [Abstract][Full Text] [Related]
10. Biologic treatment of large-vessel vasculitides.
Schäfer VS; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):31-7. PubMed ID: 22089099
[TBL] [Abstract][Full Text] [Related]
11. A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis.
Misra DP; Sharma A; Kadhiravan T; Negi VS
Autoimmun Rev; 2017 Feb; 16(2):179-191. PubMed ID: 27988436
[TBL] [Abstract][Full Text] [Related]
12. Takayasu's arteritis--recent advances in imaging offer promise.
Andrews J; Mason JC
Rheumatology (Oxford); 2007 Jan; 46(1):6-15. PubMed ID: 17043053
[TBL] [Abstract][Full Text] [Related]
13. Giant cell arteritis.
Falardeau J
Neurol Clin; 2010 Aug; 28(3):581-91. PubMed ID: 20637990
[TBL] [Abstract][Full Text] [Related]
14. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
Azhar SS; Tang RA; Dorotheo EU
Geriatrics; 2005 Aug; 60(8):26-30. PubMed ID: 16092890
[TBL] [Abstract][Full Text] [Related]
15. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
[TBL] [Abstract][Full Text] [Related]
16. Unilateral proptosis resulting from giant-cell arteritis.
Looney BD
J Am Optom Assoc; 1999 Jul; 70(7):443-9. PubMed ID: 10485174
[TBL] [Abstract][Full Text] [Related]
17. [Vasculitis of the large arteries].
Schmidt JA; von Bierbrauer A; von Wichert P
Internist (Berl); 1993 Jul; 34(7):615-21. PubMed ID: 8103509
[No Abstract] [Full Text] [Related]
18. Management of large-vessel vasculitis.
Salvarani C; Hatemi G
Curr Opin Rheumatol; 2019 Jan; 31(1):25-31. PubMed ID: 30461542
[TBL] [Abstract][Full Text] [Related]
19. Giant cell and Takayasu's arteritis.
Bengtsson BA; Andersson R
Curr Opin Rheumatol; 1991 Feb; 3(1):15-22. PubMed ID: 1675113
[TBL] [Abstract][Full Text] [Related]
20. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
